DuPont de Nemours, Inc. (DD) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company raised its earnings guidance, announced a significant share repurchase plan, and demonstrated strong performance in key sectors like healthcare and water. The Q&A revealed operational excellence initiatives and a robust M&A pipeline, further supporting growth. Although there are some uncertainties, such as the timing benefit and construction market outlook, the overall sentiment is positive, with strong management confidence in achieving growth targets.
Key Financial Performance
Net Sales $3.1 billion, increased 7% year-over-year (6% organic sales growth and 1% currency benefit). Organic sales growth included a 7% increase in volume, partially offset by a 1% decline in price. A $70 million benefit from order timing shifts contributed to this growth.
Operating EBITDA $840 million, increased 6% year-over-year. Growth driven by organic sales and productivity benefits, partially offset by growth investments and unfavorable mix. Operating EBITDA margin was 27.3%, down 30 basis points year-over-year due to unfavorable mix in ElectronicsCo.
Adjusted EPS $1.09 per share, flat year-over-year. Higher segment earnings of $0.09 were offset by a higher tax rate (24.6% compared to 19.5% in the prior year).
Transaction-Adjusted Free Cash Flow $576 million, with a conversion rate of 126%, in line with expectations.
IndustrialsCo Net Sales $1.8 billion, up 5% year-over-year (4% organic growth and 1% currency benefit). Organic growth included a $30 million benefit from order timing shifts. Excluding this, organic sales growth was 2%. Growth driven by high single-digit increases in healthcare and water sales, and low single-digit growth in diversified industrial sales.
IndustrialsCo Operating EBITDA $465 million, up 4% year-over-year. Growth driven by organic sales and productivity gains, partially offset by growth investments. Operating EBITDA margin was 25.9%, flat year-over-year.
ElectronicsCo Net Sales $1.3 billion, up 11% year-over-year (10% organic growth and 1% currency benefit). Organic growth included a $40 million benefit from order timing shifts. Excluding this, organic sales growth was 7%. Growth driven by high single-digit increases in semiconductor technologies and low teens growth in interconnect solutions.
ElectronicsCo Operating EBITDA $403 million, up 6% year-over-year. Growth driven by organic sales, partially offset by growth investments. Operating EBITDA margin was 31.6%, down 140 basis points year-over-year due to unfavorable mix and currency headwinds.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Tyvek APX launch: DuPont introduced Tyvek APX, a new technology for PPE that enhances readability while maintaining protection and durability.
Reverse osmosis expansion in China: DuPont signed an agreement to acquire manufacturing capacity in China to expand its reverse osmosis footprint, aligning with its local-for-local strategy to meet growing demand for industrial water purification and reuse.
Enhanced KPIs and business system: DuPont introduced a core set of enhanced KPIs and refreshed management standards to improve shareholder, customer, and employee outcomes. This includes a transparent, data-driven process for pipeline discipline and operational excellence.
Operational excellence improvements: Updated KPIs focused on safety, quality, delivery, and cost. Refreshed toolkit for OEE and reliability reduced unplanned downtime and improved maintenance spend.
Qnity separation: DuPont completed the separation of Qnity, positioning it as a pure-play technology solutions partner for the semiconductor value chain.
Capital allocation updates: DuPont announced a $0.20 per share quarterly dividend and a $2 billion share repurchase authorization, including a $500 million ASR, reflecting a disciplined capital allocation model.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: Ongoing weakness in construction end markets is expected to partially offset strong demand in healthcare and water, impacting organic sales growth.
Regulatory and Taxation: The full year base tax rate is expected to be about 28%, including a 200 basis points headwind related to total company interest expense that cannot be reflected as discontinued operations.
Operational Challenges: Unfavorable mix in ElectronicsCo led to a 140 basis points decline in operating EBITDA margin year-over-year. Additionally, there are challenges in reducing unplanned downtime and improving maintenance spend and rent time.
Economic Uncertainties: Currency headwinds have impacted operating EBITDA margins in both IndustrialsCo and ElectronicsCo, and slightly lower currency benefits are expected for the full year sales guidance.
Strategic Execution Risks: Growth investments to support advanced node transitions and AI technology ramps have partially offset organic growth in ElectronicsCo, indicating potential risks in achieving desired returns on these investments.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Full Year 2025 Earnings Guidance: DuPont has raised its full-year operating EBITDA guidance to $1.6 billion, driven by stronger third-quarter performance, operational improvements, and lower corporate costs. Adjusted EPS for the full year is expected to be $1.66 per share, reflecting a 16% year-over-year increase.
Organic Sales Growth: DuPont expects organic sales growth of 2% year-over-year for the full year 2025, supported by strong demand in healthcare and water markets, partially offset by ongoing weakness in construction end markets.
Fourth Quarter 2025 Guidance: For the fourth quarter, DuPont estimates net sales of about $1.685 billion, operating EBITDA of about $385 million, and adjusted EPS of $0.43 per share. Organic sales growth is expected to be 1% when normalized for third-quarter timing shifts.
Medium-Term Targets (2026-2028): DuPont aims for 3%-4% organic growth, 150-200 basis points of margin expansion, 8%-10% EPS growth, and free cash flow conversion greater than 90%.
Capital Allocation Updates: DuPont announced a $2 billion share repurchase authorization, including a $500 million accelerated share repurchase (ASR). The company also declared an initial quarterly dividend of $0.20 per share, aligning with a 35%-45% payout ratio.
Reverse Osmosis Expansion in China: DuPont plans to expand its reverse osmosis manufacturing capacity in China to meet growing demand for industrial water purification and reuse, aligning with its local-for-local strategy.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividend: Declared an initial quarterly dividend of $0.20 per share under the new DuPont, aligning with a targeted 35% to 45% payout ratio.
Share Repurchase Authorization: Approved a $2 billion share repurchase authorization, with plans to quickly launch an accelerated share repurchase (ASR) program amounting to $500 million.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What was the reason behind the timing benefit mentioned in the earnings call?
A:The timing benefit was customer-driven. Due to a blackout period in early October caused by the company's separation process, some orders originally set for October were accelerated into the third quarter. This resulted in higher organic growth in Q3 and lower organic growth in Q4.
Q:What are the company's initial thoughts on 2026 exit rates and growth in healthcare and water businesses?
A:The company expects to exit the second half at about 2% organic growth, in line with the full year. Healthcare and water businesses are expected to grow at about 5% organic growth on average, consistent with medium-term targets. Shelter is expected to normalize to flat, which would provide a lift heading into 2026.
Q:What is the company's plan for the balance sheet and leverage?
A:The company expects pro forma debt to be around $3.25 billion and $1 billion in cash, with a net debt-to-EBITDA leverage of around 1.7x. The target is to stay below 2x leverage. A $2 billion share repurchase authorization was announced, with an imminent $500 million ASR. The company also plans to balance share buybacks and M&A activity.
Q:What are the company's plans for operational excellence and lean initiatives?
A:The company hired David Cook from Danaher to lead operational excellence. They are enhancing management standards, deploying lean and six-sigma tools, and focusing on continuous improvement. Eight core KPIs have been identified to monitor performance and drive productivity.
Q:What opportunities does the company see in pruning the portfolio and focusing on secular growth markets?
A:The company aims to shift its portfolio towards more secular-based end markets, targeting a 2/3 healthcare and water mix versus the current 50-50 split. They are deploying the 80/20 framework to improve margins and identify opportunities for portfolio adjustments.
Q:What is driving the pro forma EBITDA forecast increase?
A:The increase is attributed to stronger margin performance and better operational performance, rather than volume growth.
Q:What is the company's M&A strategy and pipeline?
A:The company has a robust M&A pipeline, particularly in healthcare due to market fragmentation. They recently acquired RO capacity in China to enhance local production. They are also exploring opportunities in water systems and healthcare CDMO assets.
Q:What is the company's strategy for the water portfolio?
A:The company plans to expand beyond water filtration into systems plays and other areas of filtration. They recently acquired RO capacity in China to support local production and meet growing local preferences.
Q:What is the company's outlook for the construction market and Shelter business?
A:The Shelter business is expected to be down about 4% organically for the year but is anticipated to stabilize or show slight growth next year. The company expects the construction market to improve in the second half of next year.
Q:What is the company's confidence in achieving its 3%-4% top-line growth target for 2026?
A:The company is confident due to strong performance in healthcare and water businesses, which are expected to grow at 5% organic growth. The diversified industrials segment is expected to achieve low single-digit growth, and the Shelter business is anticipated to stabilize.
Q:What is the company's view on its GICS classification and valuation?
A:The company is pushing for a reclassification to better reflect its multi-industrial portfolio. They believe their valuation will be driven by consistent performance rather than classification. They aim to be compared to multi-industrial peers rather than chemical companies.
Q:What is the company's outlook for the healthcare business?
A:The healthcare business is performing well, with mid- to high single-digit growth. The company is seeing strong performance in biopharma, medical packaging, and medical devices. They recently hired a new leader for the healthcare business to drive further growth.
Q:What is the company's performance in diversified industrials, particularly in auto and aerospace?
A:The diversified industrials segment showed low single-digit organic growth, with strong performance in next-gen mobility, including automotive and aerospace. The company is optimistic about continued growth in these areas, particularly in EV battery opportunities.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on potential portfolio pruning targets, the exact timing of GICS reclassification, and the specific businesses that might be divested to achieve a 2/3 healthcare and water mix. Additionally, they did not provide detailed breakdowns of margin contributions by segment or specific growth rates for diversified industrials.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
APX technology
ASR amount
Ann Giancristoforo
Aramids Slide
Asia enhancement
China aligns
Day basis
Day system
Directors share
DuPont Instructions
DuPont amount
DuPont detail
DuPont form
DuPont value
ElectronicsCo IndustrialsCo
Europe improvement
Garment Tyvek
Investor Day
allocation model
capacity
capital allocation
dividend
excellence
launch
repurchase authorization
rigor
set KPIs
share repurchase
solution
value creation
water
DD Transcript
DuPont de Nemours, Inc. (DD) Q1 2026 Earnings Call Transcript
Unknown5-5
The earnings call summary presents mixed signals. Positive elements include strong margins, productivity gains, and strategic positioning in the healthcare and automotive segments. However, concerns arise from flat organic sales, construction market weakness, and uncertainties related to Middle East logistics. The Q&A section revealed management's avoidance of addressing potential demand destruction. These factors balance out, suggesting a neutral stock price reaction.
DuPont de Nemours, Inc. (DD) Q4 2025 Earnings Call Transcript
Positive2-10
The earnings call summary and Q&A session reveal strong financial metrics, optimistic guidance, and positive shareholder returns, including a $2 billion share repurchase plan. Despite some concerns about regional sales and margin details, the overall sentiment is positive with raised guidance and strategic initiatives like the reverse osmosis expansion in China. These factors suggest a likely positive stock price movement in the short term.
DuPont de Nemours, Inc. (DD) Q3 2025 Earnings Call Transcript
Positive11-6
The company raised its earnings guidance, announced a significant share repurchase plan, and demonstrated strong performance in key sectors like healthcare and water. The Q&A revealed operational excellence initiatives and a robust M&A pipeline, further supporting growth. Although there are some uncertainties, such as the timing benefit and construction market outlook, the overall sentiment is positive, with strong management confidence in achieving growth targets.
DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript
Positive8-5
DuPont's earnings call indicates a positive sentiment with strong growth expectations in healthcare and water, a well-positioned electronics segment, and a strategic focus on M&A in fragmented markets. The Qnity spin-off and effective tariff mitigation further boost confidence. Despite some uncertainties, such as the Aramids divestment, the overall outlook is optimistic, suggesting a positive stock price movement.
DD Slides
DD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
